Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, CA, 90069, USA.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Cancer Causes Control. 2024 Jan;35(1):133-151. doi: 10.1007/s10552-023-01771-2. Epub 2023 Aug 21.
In the United States, inequities in preventive health behaviors such as cervical cancer screening have been documented. Sexual orientation, gender identity, and race/ethnicity all individually contribute to such disparities. However, little work has investigated their joint impact on screening behavior.
Using sampling weighted data from the 2016 and 2018 Behavioral Risk Factor Surveillance System, we assessed differences in two metrics via chi-square statistics: 1) lifetime uptake, and 2) up-to-date cervical cancer screening by sexual orientation and gender identity, within and across racial/ethnic classifications.
Within all races, individuals who identify as members of sexual and gender minority (SGM) communities reported higher rates of never being screened (except for Black transgender men) than straight or cisgender individuals (p < 0.0001). [START Across all races, the Asian/Pacific Islander transgender population (32.4%; weighted n (w.n.) = 1,313) had the lowest proportion of lifetime screening, followed by the Asian/Pacific Islander gay/lesbian (53.0%, w.n. = 21,771), Hispanic transgender (58.7%; w.n. = 24,780), Asian/Pacific Islander bisexual (61.8%, w.n. = 54,524), and Hispanic gay/lesbian (69.6%, w.n. = 125,781) populations. END] Straight or cisgender Non-Hispanic White (w.n. = 40,664,476) individuals had the highest proportion of lifetime screening (97.7% and 97.5%, respectively). However, among individuals who had been screened at least once in their lifetime, identifying as SGM was not associated with a decreased proportion of up-to-date screening within or between races.
Due to small sample sizes, especially among Asian/Pacific Islander and Hispanic populations, confidence intervals were wide. Heterogeneity in screening participation by SGM status within and across racial/ethnic groups were observed.
These screening disparities reveal the need to disaggregate data to account for intersecting identities and for studies with larger sample sizes to increase estimate reliability.
在美国,已经记录到了预防保健行为方面的不平等,例如宫颈癌筛查。性取向、性别认同和种族/民族都各自促成了这种差异。然而,很少有研究调查它们对筛查行为的共同影响。
使用 2016 年和 2018 年行为风险因素监测系统的抽样加权数据,我们通过卡方检验评估了两个指标的差异:1)终身接受率;2)根据性取向和性别认同,在种族/民族分类内和跨分类的最新宫颈癌筛查情况。
在所有种族中,被认定为性少数群体和性别少数群体(SGM)社区成员的人报告从未接受过筛查的比例(除了黑人跨性别男性)高于直人或顺性别者(p<0.0001)。[开始在所有种族中,亚太裔跨性别者群体(32.4%;加权 n(w.n.)=1313)的终身筛查比例最低,其次是亚太裔同性恋/双性恋者(53.0%,w.n.=21771),西班牙裔跨性别者(58.7%,w.n.=24780),亚太裔双性恋者(61.8%,w.n.=54524)和西班牙裔同性恋/双性恋者(69.6%,w.n.=125781)。结束]直人或顺性别非西班牙裔白人(w.n.=40664476)的终身筛查比例最高(分别为 97.7%和 97.5%)。然而,在一生中至少接受过一次筛查的人群中,性少数群体的身份与种族内或种族间未接受最新筛查的比例无关。
由于样本量较小,特别是在亚太裔和西班牙裔人群中,置信区间较宽。在种族/民族内和跨种族/民族群体中观察到 SGM 状态与筛查参与的异质性。
这些筛查差距表明需要细分数据以考虑到交叉身份,并需要进行更大样本量的研究以提高估计的可靠性。